Queen Mary University of London

Shape registration with learned deformations for 3D shape reconstruction from sparse and incomplete point clouds (2021) Chen X, Ravikumar N, Xia Y, Attar R, Diaz-Pinto A, Piechnik SK, Neubauer S, et al. Journal article STAR: SIMULTANEOUS TRANSMISSION AND REFLECTION FOR 360 degrees COVERAGE BY INTELLIGENT SURFACES (2021) Liu Y, Mu X, Xu J, Schober R, Hao Y, Poor HV, Hanzo L Journal article Changes in blood pressure after crossover to ultrasound renal denervation in patients initially treated with sham in the RADIANCE-HTN SOLO trial (2021) Mahfoud F, Bloch MJ, Azizi M, Wang Y, Schmieder R, Lobo MD, Sharp ASP, et al. Journal article Expert opinion on COVID-19 vaccination and the use of cladribine tablets in clinical practice (2021) Rieckmann P, Centonze D, Giovannoni G, Hua LH, Oreja-Guevara C, Selchen D, Sorensen PS, et al. Journal article, Review article Bi-allelic variants in SPATA5L1 lead to intellectual disability, spastic-dystonic cerebral palsy, epilepsy, and hearing loss (2021) Richard EM, Bakhtiari S, Marsh AP, Kaiyrzhanov R, Wagner M, Shetty S, Pagnozzi A, et al. Journal article Beyond-Mild Psoriasis: A Consensus Statement on Calcipotriol and Betamethasone Dipropionate Foam for the Topical Treatment of Adult Patients (2021) Aschoff R, Bewley A, Dattola A, De Simone C, Lahfa M, Llamas-Velasco M, Martorell A, et al. Journal article Assessment of genetic defects, baseline characteristics and adverse events reported in the Increlex (R) registry (2021) Polak M, Bang P, Perrot V, Sert C, Storr HL, Wölfle J Conference contribution KEYNOTE-522: Phase III study of neoadjuvant pembrolizumab D chemotherapy vs. placebo D chemotherapy, followed by adjuvant pembrolizumab vs. placebo for earlystage TNBC (2021) Schmid P, Cortes J, Dent R, Pusztai L, Mcarthur H, Kummel S, Bergh J, et al. Conference contribution European Society of Hypertension position paper on renal denervation 2021 (2021) Schmieder R, Mahfoud F, Mancia G, Azizi M, Boehm M, Dimitriadis K, Kario K, et al. Journal article Catheter-based alcohol-mediated renal denervation for the treatment of uncontrolled hypertension: design of two sham-controlled, randomized, blinded trials in the absence (TARGET BP OFF-MED) and presence (TARGET BP I) of antihypertensive medications (2021) Mahfoud F, Weber M, Schmieder R, Lobo MD, Blankestijn PJ, Persu A, Fischell TA, et al. Journal article